A Multicenter, Open-Label, Extension Study Evaluating the Safety and Efficacy of Bomedemstat for the Treatment of Participants Enrolled in a Prior Bomedemstat Clinical Study
Clinical Trial Grant
Awarded By
Merck Sharp & Dohme LLC.
Start Date
April 23, 2025
End Date
April 20, 2030
Awarded By
Merck Sharp & Dohme LLC.
Start Date
April 23, 2025
End Date
April 20, 2030